In patients with comorbid chronic pain and substance use disorders, developing protocols for continuing opioid therapy are key for patient safety, W. Clay Jackson, MD, and Arwen Podesta, MD, DFASAM, DFAPA, ABIHM, told Psych Congress 2020 attendees.
A New Jersey law enacted in 2017 to require doctors to warn patients of the addictive potential of prescription opioids and discuss alternatives has had a significant effect on prescribing, a recently released study shows.
John Temple, author of “American Pain,” will share findings from his book on a Florida pain clinic that recklessly prescribed opioids, as well as how some operators have now shifted into running treatment centers and sober living facilities.
Las Vegas Recovery Center chief medical officer Mel Pohl, MD, DFASAM, shared risks of using opioids to treat chronic pain and offered non-medication alternatives to improve patients’ ability to function on Thursday at NCAD West.
The lifetime prevalence of a substance use disorder (SUD) hovers around 20% in the general population. The lifetime prevalence of chronic pain is about the same. Rates of both are much higher, however, in the psychiatric patient population.